Post-Conference Perspectives: Advances in the Management of Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia - Episode 4

Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL

,

Dr Aldoss discusses the role ponatinib and blinatumomab in the management of Ph+ALL.

EP. 1: Defining and Diagnosing Philadelphia Chromosome-Positive (Ph+) ALL
EP. 2: Evolving Standard of Care for Patients Diagnosed with Ph+ ALL
EP. 3: Recent Updates from the PhALLCON Study
Now Viewing
EP. 4: Ponatinib and Blinatumomab Use in Patients with Newly Diagnosed Ph+ ALL
EP. 5: Notable Advancements in Treatment for ALL
EP. 6: Unmet Needs and Treatment Trajectory for Patients Diagnosed with Ph+ ALL